Global HIV Drugs Market is valued at approximately USD 34.28 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 4.5% over the forecast period 2024-2032. Read the Market ...

PEPFAR had been set to lead the rollout of Gilead Science's lenacapavir, which has been hailed as a "miracle" of HIV ...

Advances in molecular biology and virology have facilitated the discovery of new therapeutic targets and the development of drugs with novel mechanisms of action. The rising global burden of HIV ...

The number of people living with HIV in South Africa has reached the eight million mark for the first time. About 6.2 million ...

Tomas Cihlar knew all too well that despite initial successes with combination treatment, HIV was firmly holding ground ...

Scientists aim to eliminate or reduce hidden traces of HIV in the body so the immune system can keep the virus in check ...

If the past four decades have taught us anything about HIV, it's to adjust our expectations—despite enormous progress in ...

A modeling study looked at how anticipated cuts to international HIV funding would affect the rate of new cases and ...

The number of people living with HIV in South Africa continues to rise, surpassing eight million in 2024. This is according ...